Molecular epidemiology of DNA repair genes in bladder cancer.

Molecular epidemiology of DNA repair genes in bladder cancer.

Bladder cancer is a common disease, whose major risk factors include smoking and occupational exposure to chemicals. Superficial bladder cancer has significant healthcare cost implications due to the need for repeated cystoscopic surveillance. Chemical carcinogens can undergo metabolic activation an...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awdur:	Kiltie, A
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2009

Eitemau Tebyg

DNA repair gene XRCC1 polymorphisms and bladder cancer risk
gan: Sak, S, et al.
Cyhoeddwyd: (2007)

DNA repair gene <it>XRCC1 </it>polymorphisms and bladder cancer risk
gan: Bishop D Timothy, et al.
Cyhoeddwyd: (2007-04-01)

RAD51: A DNA repair target for increasing the therapeutic potential in bladder cancer
gan: Choudhury, A, et al.
Cyhoeddwyd: (2005)

Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.
gan: Stern, M, et al.
Cyhoeddwyd: (2009)

DNA repair gene XPC polymorphisms, smoking, occupational exposures and the risk of bladder transitional cell carcinoma
gan: Sak, S, et al.
Cyhoeddwyd: (2005)

Analysis of variants in DNA damage signalling genes in bladder cancer
gan: Choudhury, A, et al.
Cyhoeddwyd: (2008)

Using gene polymorphisms to assess bladder cancer risk: progress and challenges.
gan: Kiltie, A
Cyhoeddwyd: (2012)

Using gene polymorphisms to assess bladder cancer risk: Progress and challenges
gan: Kiltie, A
Cyhoeddwyd: (2012)

DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining.
gan: Bentley, J, et al.
Cyhoeddwyd: (2004)

The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes.
gan: Teo, M, et al.
Cyhoeddwyd: (2012)

Analysis of variants in DNA damage signalling genes in bladder cancer
gan: Bishop D Timothy, et al.
Cyhoeddwyd: (2008-07-01)

Gene Expression, DNA Methylation and Prognostic Significance of DNA Repair Genes in Human Bladder Cancer
gan: Anita Wojtczyk-Miaskowska, et al.
Cyhoeddwyd: (2017-08-01)

Prognostic Analysis of Differentially Expressed DNA Damage Repair Genes in Bladder Cancer
gan: Yong Yang, et al.
Cyhoeddwyd: (2022-05-01)

Common predisposition alleles for moderately common cancers: bladder cancer.
gan: Kiltie, A
Cyhoeddwyd: (2010)

Gemcitabine as a Chemoradiosensitiser in Bladder Cancer
gan: Kerr, M, et al.
Cyhoeddwyd: (2012)

How can we utilise DNA repair assays in prediction of radiation response?
gan: Kiltie, A
Cyhoeddwyd: (2009)

Utility of bladder-sparing therapy vs radical cystectomy for muscle-invasive bladder cancer
gan: Efstathiou, J, et al.
Cyhoeddwyd: (2018)

Predictive Biomarkers for Gemcitabine as a Chemoradiosensitizer in Bladder Cancer
gan: Kerr, M, et al.
Cyhoeddwyd: (2012)

Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and KU DNA-binding activities.
gan: Bentley, J, et al.
Cyhoeddwyd: (2009)

Attenuated XPC expression is not associated with impaired DNA repair in bladder cancer.
gan: Kishan A T Naipal, et al.
Cyhoeddwyd: (2015-01-01)

DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk: a meta-analysis.
gan: Shan Li, et al.
Cyhoeddwyd: (2013-01-01)

Epidemiology of Bladder Cancer
gan: Kalyan Saginala, et al.
Cyhoeddwyd: (2020-03-01)

Differential Roles of DNA Repair Proteins in the MMEJ Phenotype
gan: Brideau, C, et al.
Cyhoeddwyd: (2012)

DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes
gan: Thiago Vidotto, et al.
Cyhoeddwyd: (2019-06-01)

Downregulated XPA promotes carcinogenesis of bladder cancer via impairment of DNA repair
gan: Yi Zhi, et al.
Cyhoeddwyd: (2017-02-01)

Development of a rapid, small-scale DNA repair assay for use on clinical samples.
gan: Diggle, C, et al.
Cyhoeddwyd: (2003)

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression
gan: Groselj, B, et al.
Cyhoeddwyd: (2013)

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.
gan: Groselj, B, et al.
Cyhoeddwyd: (2013)

Genetic alterations in the molecular subtypes of bladder cancer: Illustration in the Cancer Genome Atlas dataset
gan: Choi, W, et al.
Cyhoeddwyd: (2017)

Alterations in DNA Damage Repair Genes Before and After Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
gan: Ursula Lemberger, et al.
Cyhoeddwyd: (2025-01-01)

Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature
gan: Tianhang Li, et al.
Cyhoeddwyd: (2023-03-01)

DNA damage repair gene alteration status as a predictive marker for response to neoadjuvant chemotherapy in muscle invasive bladder cancer
gan: A. Bruchbacher, et al.
Cyhoeddwyd: (2020-07-01)

Mouse models of muscle-invasive bladder cancer: Key considerations for clinical translation based on molecular subtypes
gan: Ruan, J, et al.
Cyhoeddwyd: (2018)

The role of MDM2-NBS1 protein interaction in DNA repair in bladder cancer
gan: Aare, K
Cyhoeddwyd: (2020)

Histone deacetylase inhibitors as radiosensitisers: Effects on DNA damage signalling and repair
gan: Groselj, B, et al.
Cyhoeddwyd: (2013)

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair.
gan: Groselj, B, et al.
Cyhoeddwyd: (2013)

High-throughput DNA sequencing identifies novel CtIP (RBBP8) variants in muscle-invasive bladder cancer patients
gan: Jevons, S, et al.
Cyhoeddwyd: (2015)

DNA mismatch repair genes and colorectal cancer.
gan: Wheeler, J, et al.
Cyhoeddwyd: (2000)

Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk.
gan: Sak, S, et al.
Cyhoeddwyd: (2006)

SPRTN protease-cleaved MRE11 decreases DNA repair and radiosensitises cancer cells
gan: Na, J, et al.
Cyhoeddwyd: (2021)